Trial · NCT07880184
Graftless Periosteal Coverage Versus Xenogenic Graft for Jumping Gap Management in Immediate Mandibular Molar Implants
NCT07880184, Not applicable, Recruiting, Horus University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Graftless Periosteal Coverage Versus Xenogenic Graft for Jumping Gap Management in Immediate Mandibular Molar Implants. Trials, record NCT07880184. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07880184
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Graftless Periosteal Coverage Versus Xenogenic Graft for Jumping Gap Management in Immediate Mandibular Molar Implants
- NCT number
- NCT07880184
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 56 participants, estimated
- Lead sponsor
- Horus University
- Conditions
- Dental Implants
- Interventions
- Coronally Advanced Periosteal Flap, Particulate Xenogenic Bone Graft with Collagen Membrane
- First posted
- 2026-10-19
- Last updated
- 2026-10-19
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Bone volume | 4 months post-operatively | The volume of regenerated bone within the jumping gap surrounding the dental implant will be assessed using cone-beam computed tomography (CBCT). The regenerated bone volume will be measured in cubic millimeters (mm³) using standardized CBCT images and a predefined region of interest corresponding to the jumping gap. The volumetric measurements will be performed according to a standardized image-analysis protocol. |
| Primary | Bone density | 4 months post-operatively | The radiographic density of the regenerated bone surrounding the dental implant will be assessed using cone-beam computed tomography (CBCT). Bone density will be measured in Hounsfield units (HU) within a predefined region of interest corresponding to the regenerated bone around the implant. Standardized CBCT acquisition and image-analysis protocols will be used to ensure consistency of measurements. |
| Secondary | Implant Stability | Implant stability will be assessed at baseline and after 4 months | Measurements will be obtained using an appropriate resonance frequency analysis device at the predefined assessment time points and expressed as an implant stability quotient (ISQ). The ISQ value, ranging from 1 to 100, will be recorded for each implant, with higher ISQ values indicating greater implant stability. For each implant, ISQ measurements will be obtained in two perpendicular directions, and the mean value will be calculated and used for statistical analysis. |
| Secondary | Post-operative pain | days 2, 7, and 14 post-operative | Postoperative pain will be assessed using a 10-cm Visual Analogue Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Participants will record their pain intensity at the specified postoperative time points. |
| Secondary | Patient-reported post-operative swelling | At 2, 7 and 14 days post-operative. | Visual numeric rating scale (VNRS)/numeric scale for swelling, 0-10 numerical scale, which captures the patient's perception at 2, 7 and 14 days post-operative. |
| Secondary | Postoperative complications | Postoperative days 2, 7, and 14, and monthly thereafter through 4 months. | The occurrence of postoperative complications, including membrane exposure, flap dehiscence, and postoperative infection, will be clinically assessed at each scheduled postoperative follow-up visit. Each complication will be recorded as present or absent (yes/no), and the date of occurrence will be documented. Membrane exposure will be assessed in participants receiving the collagen membrane, while flap dehiscence and postoperative infection will be assessed in both treatment groups. |
| Secondary | Objective facial swelling | Pre-operative (baseline), and then 2, 7 and 14 days post-operative | Standardized facial measurements in mm, will be measured at baseline + postoperative follow-ups. Postoperative facial swelling will be assessed using standardized facial linear measurements. Three facial distances (tragus to corner of mouth, tragus to pogonion, and angle of mandible to corner of mouth) will be measured preoperatively as baseline and postoperatively on days 2, 7 and 14 using a flexible measuring tape. All measurements will be performed by the same calibrated examiner using standardized anatomical landmarks and with the patient in a standardized seated position. The change in each facial measurement from baseline will be recorded as an objective measure of postoperative swelling. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07880184
GET https://conductscience.org/api/trials/v1/NCT07880184/registered